12/22/2006

A report says under-the-tongue immunotherapy is cost-effective to treat adults with pollen-induced respiratory allergies. Researchers reviewing the therapy, which is undergoing clinical trails in the U.S., said they found that the treatment can lead to savings by reducing rhinitis and drug consumption.

Full Story:
Reuters

Related Summaries